LAURA SAMUEL: Open Payments
NPI 1871122036 · TIMMONSVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,903 in 89 payments from 16 companies in 2025. Trend: 2023 $1,021 · 2024 $1,097 · 2025 $1,903
Food & beverage: $1,903
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $559 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $358 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $245 |
| Amgen Inc. | 6 | $193 |
| AstraZeneca Pharmaceuticals LP | 7 | $141 |
| Forte Bio-Pharma LLC | 7 | $124 |
| Abbott Laboratories | 3 | $59 |
| Lilly USA, LLC | 4 | $59 |
| Novo Nordisk Inc | 1 | $32 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
Products named: VRAYLAR, CAPLYTA, Kerendia, PROLATE, KRYSTEXXA, AIRSUPRA, OTEZLA, FREESTYLE LIBRE 3.
Industry payments across SC — which companies pay providers there.
